FMP

FMP

Enter

NUWE - Nuwellis, Inc.

photo-url-https://images.financialmodelingprep.com/symbol/NUWE.png

Nuwellis, Inc.

NUWE

NASDAQ

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

0.99 USD

-0.01 (-1.01%)

Historical Prices

From:

To:

0.9550.960.970.980.9911.011.0209:30 AM09:39 AM10:28 AM10:50 AM11:40 AM12:01 PM12:56 PM01:46 PM02:33 PM03:05 PM03:18 PM03:26 PM03:34 PM03:50 PM

About

ceo

Mr. John L. Erb

sector

Healthcare

industry

Medical - Devices

exchange

NASDAQ

Description

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, ...

CIK

0001506492

ISIN

US67113Y4052

CUSIP

12542Q706

Address

12988 Valley View Road

Phone

952 345 4200

Country

US

Employee

38

IPO Date

Feb 16, 2012

Financial Statement

-8M-6M-4M-2M02M4M2023 Q42024 Q12024 Q22024 Q32024 Q4RevenueNet Income

Earnings

-150-120-90-60-300302023 Q22023 Q32023 Q42024 Q12024 Q22024 Q32024 Q42025 Q1EPS Consensus

NUWE Financial Summary

CIK

0001506492

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

12542Q706

ISIN

US67113Y4052

Country

US

Price

0.99

Beta

0.51

Volume Avg.

147.78k

Market Cap

4.33M

Shares

-

52-Week

0.75-12.6

DCF

1.1

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.12

P/B

-

Website

https://www.nuwellis.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest NUWE News

Seeking Alpha

Aug 13, 2024

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

Nuwellis, Inc. (NASDAQ:NUWE ) Q2 2024 Earnings Conference Call August 13, 2024 9:00 AM ET Company Participants Vivian Cervantes - Gilmartin Group, Investor Relations Nestor Jaramillo - President, CEO & Director Rob Scott - Chief Financial Officer Conference Call Participants Jonathan Aschoff - Roth Anthony Vendetti - Maxim Group Operator Good morning. And welcome to the Nuwellis Earnings Conference Call for the Second Quarter ended June 30th, 2024.

GlobeNewsWire

Apr 30, 2024

Nuwellis, Inc. To Report First Quarter 2024 Financial Result...

MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) --  Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the first quarter of 2024 on Tuesday, May 7, 2024. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update.

GlobeNewsWire

Feb 27, 2024

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 F...

MINNEAPOLIS, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the fourth quarter and full year of 2023 on Tuesday, March 5, 2024. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update.

GlobeNewsWire

Feb 20, 2024

Nuwellis to Announce Late-Breaking Clinical Data and Host Sa...

Nuwellis to share three presentations highlighting the company's Aquadex SmartFlow system Nuwellis to share three presentations highlighting the company's Aquadex SmartFlow system

Zacks Investment Research

Nov 13, 2023

Here's Why Nuwellis, Inc. (NUWE) Is a Great 'Buy the Bottom'...

Nuwellis, Inc. (NUWE) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Seeking Alpha

Nov 7, 2023

Nuwellis, Inc. (NUWE) Q3 2023 Earnings Call Transcript

Nuwellis, Inc. (NASDAQ:NUWE ) Q3 2023 Earnings Conference Call November 7, 2023 9:00 AM ET Company Participants Vivian Cervantes - IR Nestor Jaramillo - President and CEO John Jefferies - Chief Medical Officer Rob Scott - CFO Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Anthony Vendetti - Maxim Group Operator Good day, and welcome to the Nuwellis third-quarter 2023 earnings conference call. [Operator Instructions].

GlobeNewsWire

Oct 18, 2023

Nuwellis, Inc. To Announce Third Quarter 2023 Financial Resu...

MINNEAPOLIS, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, announced today that its third quarter 2023 financial results will be released on Tuesday, November 7, 2023. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss the company's financial results and provide a general business overview.

GlobeNewsWire

Sep 11, 2023

Nuwellis to Present at the Gilmartin Group Emerging Growth S...

MINNEAPOLIS, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of people with fluid overload, today announced that President and Chief Executive Officer Nestor Jaramillo, Chief Financial Officer Rob Scott, and Chief Medical Officer Dr. John Jefferies, will participate in a fireside chat at the upcoming Gilmartin Group Emerging Growth Showcase on Thursday, September 21, 2023, at 12:00 pm ET.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep